Table 6.
GI Symptoms | Control | Intervention |
p-Value Intervention |
||
---|---|---|---|---|---|
Baseline | 2 weeks | Baseline | 2 weeks | ||
IBS-SSS total score | 310 (247–351) |
271 (238–325) |
306 (250–356) |
190 (118–282) |
<0.001 |
Abdominal pain | 49 (27–62) | 48 (26–63) | 52 (37–65) | 29 (8–52) | <0.001 |
Diarrhea | 47 (5–70) | 33 (6–62) | 57 (18–76) | 18 (2–56) | <0.001 |
Constipation | 54 (30–69) | 28 (2–68) | 47 (1–73) | 22 (0–50) | <0.001 |
Bloating and flatulence | 78 (68–89) | 76 (54–87) | 78 (60–85) | 46 (12–61) | <0.001 |
Vomiting and nausea | 29 (6–50) | 20 (3–38) | 11 (1–34) | 4 (0–28) | 0.003 |
Psychological well-being | 47 (24–71) | 49 (31–66) | 50 (24–69) | 41 (14–60) | 0.002 |
Intestinal symptoms’ influence on daily life | 68 (53–78) | 68 (63–84) | 72 (52–86) | 49 (19–68) | <0.001 |
Missing value | 0 | 5 | 2 | 6 |
The control group continued with their ordinary food habits during the two-week observational time period. Comparisons before and after two weeks was performed by Wilcoxon test. No statistically significant differences were found before and after two weeks in the control group, wherefore, p-values are not shown. Values are presented as median and interquartile rages (IQR). p < 0.05 was considered statistically significant.